Antidepressant controlled trial for negative symptoms in schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial.
<h4>Background</h4> <p>Negative symptoms of schizophrenia represent deficiencies in emotional responsiveness, motivation, socialisation, speech and movement. When persistent, they are held to account for much of the poor functional outcomes associated with schizophrenia. There are...
Hlavní autoři: | Barnes, T, Leeson, V, Paton, C, Costelloe, C, Simon, J, Kiss, N, Osborn, D, Killaspy, H, Craig, T, Lewis, S, Keown, P, Ismail, S, Crawford, M, Baldwin, D, Lewis, G, Geddes, J, Kumar, M, Pathak, R, Taylor, S |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
National Institute for Health Research
2016
|
Podobné jednotky
-
Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial
Autor: Thomas RE Barnes, a další
Vydáno: (2016-04-01) -
Long-term antidepressant treatment for negative symptoms in schizophrenia: the actions study
Autor: Barnes, T, a další
Vydáno: (2017) -
Disclosing the potential impact of placebo controls in antidepressant trials
Autor: Stephanie C. Chen, a další
Vydáno: (2015-06-01) -
Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness
Autor: Thomas RE Barnes, a další
Vydáno: (2017-09-01) -
Adverse effects from antidepressant treatment: randomised controlled trial of 601 depressed individuals.
Autor: Crawford, A, a další
Vydáno: (2014)